CreatorsPublishersAdvertisers
View more in
Cancer

Benefit of Immunotherapy Combination for Patients With Advanced Melanoma Extends to Subsequent Treatment

Cancer Health
Cancer Health
 28 days ago
Cover picture for the article

A combination of two immunotherapy drugs, already shown to be more effective in patients with advanced melanoma than one of the drugs alone, also prolongs the benefit to patients who receive subsequent therapies, a clinical trial led by Dana-Farber Cancer Institute investigators indicates. The findings [were presented September 18] at the 2021 Congress of the European Society of Medical Oncology (ESMO).

www.cancerhealth.com

Comments / 0

Comments / 0